In this study, we found that the levels of GP73 both in serum and liver tissues increased significantly in NASH patients with a severe liver necroinflammatory grade compared to those with no or mild inflammation. The gene discussed is GOLM1; the disease is metabolic dysfunction-associated steatohepatitis.